Sen. Mattie Hunter
Filed: 2/28/2020
 
 

 

 

 
10100SB3107sam001LRB101 20270 KTG 70952 a



1
AMENDMENT TO SENATE BILL 3107




2    AMENDMENT NO. ______. Amend Senate Bill 3107 by replacing 
3everything after the enacting clause with the following:

 
 
4    "Section 1. Short title. This Act may be cited as the 
5Sickle Cell Prevention, Care, and Treatment Program Act.
 
6    Section 5. Definitions. As used in this Act:
7    "Department" means the Department of Public Health.
8    "Program" means the Sickle Cell Prevention, Care, and 
9Treatment Program.
 
10    Section 10. Sickle Cell Prevention, Care, and Treatment 
11Program. The Department shall establish a grant program for the 
12purpose of providing for the prevention, care, and treatment of 
13sickle cell disease and for educational programs concerning the 
14disease.
 
 
 
10100SB3107sam001- 2 -LRB101 20270 KTG 70952 a

1    Section 15. Grants; eligibility standards.
2    (a) The Department shall do the following:
3        (1)(A) Develop application criteria and standards of 
4    eligibility for groups
or organizations who apply for funds 
5    under the program.
6        (B) Make available grants to groups and organizations 
7    who meet
the eligibility standards set by the Department. 
8    However:
9            (i) the highest priority for grants shall be 
10        accorded to
established sickle cell disease

11        community-based organizations throughout Illinois; and
12            (ii) priority shall also be given to ensuring the

13        establishment of sickle cell disease centers in 
14        underserved
areas that have a higher population of 
15        sickle cell disease
patients.
16        (2) Determine the maximum amount available for each 
17    grant provided under subparagraph (B) of paragraph (1).
18        (3) Determine policies for the expiration and renewal 
19    of grants provided under subparagraph (B) of paragraph (1).
20        (4) Require that all grant funds be used for the 
21    purpose of
prevention, care, and treatment of sickle cell 
22    disease or
for educational programs concerning the 
23    disease.
Grant funds shall be used for one or more of the 
24    following purposes:
25            (A) Assisting in the development and expansion of 
26        care for the
treatment of individuals with sickle cell 
 
 
10100SB3107sam001- 3 -LRB101 20270 KTG 70952 a

1        disease, particularly
for adults, including the 
2        following types of care:
3                (i) Self-administered care.
4                (ii) Preventive care.
5                (iii) Home care.
6                (iv) Other evidence-based medical procedures 
7            and
techniques designed to provide maximum control 
8            over
sickling episodes typical of occurring to an 
9            individual with
the disease.
10            (B) Increasing access to health care for 
11        individuals with sickle cell disease.
12            (C) Establishing additional sickle cell disease 
13        infusion centers.
14            (D) Increasing access to mental health resources 
15        and pain management therapies for individuals with 
16        sickle cell disease.
17            (E) Providing counseling to any individual, at no 
18        cost, concerning sickle cell disease and sickle cell 
19        trait, and the characteristics, symptoms, and 
20        treatment of the disease.
21                (i) The counseling described in this 
22            subparagraph (E) may consist of any of the 
23            following:
24                    (I) Genetic counseling for an individual 
25                who tests positive for the sickle cell trait.
26                    (II) Psychosocial counseling for an 
 
 
10100SB3107sam001- 4 -LRB101 20270 KTG 70952 a

1                individual who tests positive for sickle cell 
2                disease, including any of the following:
3                        (aa) Social service counseling.
4                        (bb) Psychological counseling.
5                        (cc) Psychiatric counseling.

6        (5) Develop a sickle cell disease educational
outreach 
7    program that includes the dissemination of
educational 
8    materials to the following concerning sickle cell
disease 
9    and sickle cell trait:

10            (A) Medical residents.
11            (B) Immigrants.
12            (C) Schools and universities.
13        (6) Adopt any rules necessary to implement the 
14    provisions of this Act. 
15    (b) The Department may contract with an entity to
implement 
16the sickle cell disease educational outreach program
described 
17in paragraph (5) of subsection (a).

 
18    Section 20. Sickle Cell Chronic Disease Fund. 
19    (a) The Sickle Cell Chronic Disease Fund is
created as a 
20special fund in the State treasury for the purpose of carrying 
21out the provisions of this
Act and for no other
purpose. The 
22Fund shall be administered by the Department.

23    (b) The Fund shall consist of:
24        (1) Any moneys appropriated to the Department for the 
25    Sickle Cell Prevention, Care, and Treatment Program.
 
 
10100SB3107sam001- 5 -LRB101 20270 KTG 70952 a

1        (2) Gifts, bequests, and other sources of funding.
2        (3) All interest earned on moneys in the Fund.

 
3    Section 25. Study.
4    (a) Before July 1, 2021, and on a
biennial basis 
5thereafter, the Department, with the assistance
of:
6        (1) the Center for Minority Health Services;
7        (2) health care providers that treat individuals with 
8    sickle cell
disease;
9        (3) individuals diagnosed with sickle cell disease;
10        (4) representatives of community-based organizations 
11    that
serve individuals with sickle cell disease; and
12        (5) data collected via newborn screening for sickle 
13    cell disease;

14shall perform a study to determine the prevalence, impact, and

15needs of individuals with sickle cell disease and the sickle 
16cell trait in
Illinois.

17    (b) The study must include the following:
18        (1) The prevalence, by geographic location, of 
19    individuals
diagnosed with sickle cell disease in 
20    Illinois.
21        (2) The prevalence, by geographic location, of 
22    individuals
diagnosed as sickle cell trait carriers in 
23    Illinois.
24        (3) The availability and affordability of screening 
25    services in
Illinois for the sickle cell trait.

 
 
10100SB3107sam001- 6 -LRB101 20270 KTG 70952 a

1        (4) The location and capacity of the following for the

2    treatment of sickle cell disease and sickle cell trait 
3    carriers:

4            (A) Treatment centers.
5            (B) Clinics.
6            (C) Community-based social service organizations.
7            (D) Medical specialists.

8        (5) The unmet medical, psychological, and social needs

9    encountered by individuals in Illinois with sickle cell 
10    disease.
11        (6) The underserved areas of Illinois for the treatment 
12    of
sickle cell disease.

13        (7) Recommendations for actions to address any 
14    shortcomings
in the State identified under this Section.
15    (c) The Department shall submit a report on the study 
16performed
under this Section to the General Assembly.
 
17    Section 30. Implementation subject to appropriation. 
18Implementation of this Act is subject to appropriation.
 
19    Section 90. The State Finance Act is amended by adding 
20Section 5.930 as follows:
 
21    (30 ILCS 105/5.930 new)
22    Sec. 5.930. The Sickle Cell Chronic Disease Fund.".